Cargando…

SITE-LEVEL VARIABILITY IN THE PROCESSES OF CARE OVER TIME AMONG PATIENTS WITH COVID-19 AND ELEVATED TROPONIN: INSIGHTS FROM THE AMERICAN HEART ASSOCIATION'S CVD COVID-19 REGISTRY

Detalles Bibliográficos
Autores principales:	Sammour, Yasser, Kennedy, Kevin, Hayek, Salim, Enriquez, Jonathan R., Jones, Philip, Malik, Ali, Hejjaji, Vittal, Alger, Heather, Stevens, Laura, Daniels, Lori B., Morrow, David A., de Lemos, James A., Sutton, Nadia Razaq, Spertus, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2022
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972619/ http://dx.doi.org/10.1016/S0735-1097(22)03142-4

Ejemplares similares

COMPARISON OF VIDEO AND TELEPHONE VIRTUAL VISITS IN THE OUTPATIENT MANAGEMENT OF HEART FAILURE PATIENTS DURING THE COVID-19 PANDEMIC
por: Sammour, Yasser, et al.
Publicado: (2021)

TROPONIN CORRELATES WITH INFLAMMATORY MARKERS IN COVID-19
por: Klinkhammer, Brent, et al.
Publicado: (2021)

INITIAL, MAXIMUM, AND DELTA TROPONIN AND MORTALITY IN COVID-19
por: Go, Ronaldo, et al.
Publicado: (2021)

INITIAL TROPONIN LEVEL AND ECHOCARDIOGRAPHIC FINDINGS IN SEVERE COVID-19
por: Kumar, Sant, et al.
Publicado: (2021)

CLINICAL IMPACT AND PREDICTORS OF TROPONIN ELEVATION IN PATIENTS WITH COVID-19
por: Case, Brian, et al.
Publicado: (2021)

INITIAL TROPONIN LEVEL AS A COVID-19 ILLNESS PROGNOSTICATOR
por: Ruge, Max, et al.
Publicado: (2021)

PREDICTIVE VALUE OF TROPONIN, NTPROBNP AND SODIUM ON ADVERSE CLINICAL OUTCOMES IN COVID-19
por: Roman, Aida, et al.
Publicado: (2021)

Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry
por: Sammour, Yasser M., et al.
Publicado: (2023)

WORSE OUTCOMES IN OBESE YOUNG ADULTS HOSPITALIZED WITH COVID-19
por: Weinberg, Jessica, et al.
Publicado: (2022)

HIGH-SENSITIVITY CARDIAC TROPONIN T FOR THE DETECTION OF MYOCARDIAL INJURY AND RISK STRATIFICATION IN COVID-19
por: De Michieli, Laura, et al.
Publicado: (2021)

CLINICAL OUTCOMES AND PREDICTORS OF COVID-19 PATIENTS WITH TROPONIN ELEVATION AND CONCOMITANT RENAL DYSFUNCTION
por: Case, Brian, et al.
Publicado: (2021)

TROPONIN ELEVATION AS A MANIFESTATION OF COVID-19 MYOCARDIAL INFLAMMATION ASSOCIATED WITH INCREASED MORTALITY
por: Limaye, Sneha, et al.
Publicado: (2022)

COVID-19 AND HEART: ASSESSMENT OF TROPONIN AND CARDIOVASCULAR COMORBIDITIES AS PROGNOSTIC MARKERS IN PATIENTS HOSPITALIZED FOR COVID-19 IN A TERTIARY CENTER IN BRAZIL
por: Pinesi, Henrique, et al.
Publicado: (2022)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

EFFECTS OF ELEVATED TROPONIN ON MORTALITY IN HOSPITALIZED COVID-19 PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE
por: Zhao, Yi, et al.
Publicado: (2022)

PERSONALIZING THE OPTIMAL CARDIAC TROPONIN THRESHOLD FOR COVID-19 PROGNOSTICATION BASED ON PRE-EXISTING COMORBIDITIES
por: Ruge, Max, et al.
Publicado: (2022)

PROGNOSTIC VALUE OF ELEVATED HIGH-SENSITIVITY TROPONIN LEVEL IN COVID-19 ASSOCIATED HOSPITALIZATIONS IN THE SOUTH BRONX
por: Yue, Bing, et al.
Publicado: (2021)

COMPARISON OF PROGNOSTIC SIGNIFICANCE OF TROPONIN I ELEVATION TO OTHER BIOMARKERS IN PATIENTS HOSPITALIZED WITH COVID 19 INFECTION
por: Jayanna, Manju Bengaluru, et al.
Publicado: (2021)

TROPONIN ELEVATION AS A PREDICTOR FOR OUTCOMES OF PATIENTS DIAGNOSED WITH COVID 19 INFECTION IN A LARGE PUBLIC HOSPITAL IN THE CHICAGO AREA
por: Quelal, Karol, et al.
Publicado: (2021)

RELATIONSHIP BETWEEN ADMISSION TROPONIN AND OUTCOMES IN CRITICALLY ILL PATIENTS WITH HEART DISEASE AND COVID-19 IN A TERTIARY CENTER IN BRAZIL
por: Moreira, Eduardo, et al.
Publicado: (2022)

OBESITY, INFLAMMATION, AND OUTCOMES IN COVID-19
por: Padalia, Kishan, et al.
Publicado: (2021)

BIOMARKERS OF INFLAMMATION AND OUTCOMES OF PATIENTS HOSPITALIZED FOR COVID-19: THE INTERNATIONAL STUDY OF INFLAMMATION IN COVID-19
por: Meloche, Chelsea, et al.
Publicado: (2021)

TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE
por: Limani, Saurabhkumar M., et al.
Publicado: (2023)

IN-HOSPITAL OUTCOMES AMONG COVID-19 PATIENTS WITH CANCER AND CARDIOVASCULAR DISEASE
por: Tehrani, David, et al.
Publicado: (2021)

STATIN USE MAY BE ASSOCIATED WITH DECREASED SEVERITY OF COVID-19
por: Shadid, Husam, et al.
Publicado: (2021)

CARDIOVASCULAR DISEASE AND OUTCOMES IN CRITICALLY ILL PATIENTS WITH COVID-19: A STOP-COVID ANCILLARY
por: Meloche, Chelsea, et al.
Publicado: (2021)

CATHETER-DIRECTED THROMBOLYSIS IN COVID-19
por: Ammar, Ali, et al.
Publicado: (2022)

OUTCOMES OF COVID-19 IN PATIENTS WITH CARDIOVASCULAR DISEASE
por: Vu, Chau N., et al.
Publicado: (2021)

IS THERE A ROLE FOR α1-ANTITRYPSIN IN COVID-19?
por: Gurbel, Paul A., et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS AND OUTCOMES IN CARDIO-ONCOLOGY PATIENTS WITH COVID-19: ANALYSIS FROM THE COVID-19 AND CANCER CONSORTIUM (CCC19) DATABASE
por: Moey, Melissa YY, et al.
Publicado: (2021)

MORTALITY IN LATINOS WITH COVID-19, UNIVERSITY OF MIAMI EXPERIENCE
por: Montanez-Valverde, Raul A., et al.
Publicado: (2021)

WHO IS AT RISK FOR CARDIOMYOPATHY IN COVID 19
por: Daftari, Diana, et al.
Publicado: (2021)

BRADYARRHYTHMIAS AND MORTALITY IN COVID-19 PATIENTS
por: Hoang, Lawrence, et al.
Publicado: (2021)

THE EFFECT OF COVID-19 ON CARDIOVASCULAR PRODUCERS
por: Annie, Frank H., et al.
Publicado: (2021)

OUTCOMES OF PATIENTS WITH PULMONARY EMBOLISM WITH HISTORY OF COVID-19 ARE AS POOR AS PATIENTS WITH PULMONARY EMBOLISM WITH SEVERE COVID-19
por: Ho, Timothy D., et al.
Publicado: (2022)

CORONARY MICROVASCULAR HEALTH IN PATIENTS WITH PRIOR COVID-19 INFECTION: IMPLICATIONS FOR LONG-COVID SYNDROME
por: Ahmed, Ahmed Ibrahim, et al.
Publicado: (2022)

RECOVERY OF LEFT VENTRICULAR DYSFUNCTION IN HOSPITALIZED PATIENTS WITH COVID-19
por: Hiremath, Pranoti G., et al.
Publicado: (2021)

AGE-BASED RISK FACTORS FOR SYMPTOMATIC COVID-19 IN THE MINORITY POPULATION
por: Gurbel, Paul A., et al.
Publicado: (2021)

EFFECT OF STATIN IN HOSPITALIZED PATIENTS WITH COVID 19
por: Bonilla, Hilda Mariana Gonzalez, et al.
Publicado: (2021)

CARDIAC ABNORMALITIES IN COVID-19 AND RELATIONSHIP TO OUTCOME
por: Krishna, Hema, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g4d681f7u56b20253i8h973dbb